• Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: update from the GBD 2019 Study 

  Roth, Gregory A.; Mensah, George; Johnson, Catherine; Addolorato, Giovanni; Ammirati, Enrico; Baddour, Larry M.; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group; Rwegerera, Godfrey Mutashambara (Elsevier, www.elsevier.com, 2020-12-11)

  Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD ...

• Five insights from the Global Burden of Disease Study 2019 

  GBD 2019 Viewpoint Collaborators (Elsevier, www.elsevier.com, 2020-10-17)

  The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system ...

• Antimicrobial utilization research and activities in Botswana, the past, present and the future 

  Tiroyakgosi, Celda; Matome, Matshediso; Kgatlwane, Joyce; Paramadhas, Bene D Anand; Malone, Brighid; Mpinda-Joseph, Pinkie; Rwegerera, Godfrey Mutashambara; Maika, Keamogetse; Mashalla, Yohana; Godman, Brian; Maselle, Amos (Taylor & Francis, www.tandfonline.com, 2019-09-23)

  A number of activities are ongoing to reduce AMR in Botswana by improving antimicrobial utilization across all sectors. However, there is a need to share experiences. With the objective of sharing these, the second one ...

• Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana 

  Kesenogile, Boikobo; Godman, Brian; Rwegerera, Godfrey Mutashambara (Taylor & Francis. www.tandfonline.com, 2020-12-01)

  Objective: Tuberculosis (TB) remains a global health problem, with medications having adverse effects including drug-induced hepatotoxicity. We determined the prevalence of anti-tuberculosis drug-induced hepatotoxicity and ...

• Prevalence and risk Factors for hepatitis B and C among end‑stage renal disease patients on hemodialysis in Gaborone, Botswana 

  Mahupe, Ponatshego; Molefe-Baikai, Onkabetse Julia; Saleshando, Gagoitsiwe; Rwegerera, Godfrey Mutashambara (Medknow Publishers, www.medknow.com, 2021-01)

  Background: Patients on maintenance hemodialysis (HD) are at risk of blood transmitted infections such as hepatitis B and C. Objectives: To determine the prevalence and risk factors for hepatitis B and hepatitis C virus ...

View more